Nanobiotechnology and Nanomedicine Companies
Showing results 41 - 53 of 53 for companies in category Analysis in USA:
The comapny develops nanotechnology and microfluidics for DNA analysis in clinical, forensic, and genomic applications.
A protein biosensor company focused on the development of portable, electronic detection devices for use in in vitro diagnostics using nano-engineered electronic surfaces arrayed on disposable chips.
Combining recent advances in nanofabrication, biochemistry, molecular biology, surface chemistry and optics, the company has created a powerful technology platform called single molecule, real-time, or SMRT, technology. SMRT technology enables real-time analysis of biomolecules with single molecule resolution, which has the potential to transform our understanding of biological systems by providing a window into these systems that has not previously been open for scientific study.
Delivers innovative tools and solutions for Parallel Quantitative Biology (PQB) - contextual, systems-level measurements of genes, proteins and their cellular functions.
A genomics company that has developed the world's first light-powered microtransponders and nanotransponders for performing nucleic acid-based assays.
Develops and sells patented high performance, injection-molded nanospray devices for mass spectrometry applications in drug discovery, clinical diagnostics and homeland security.
Promega's products are used in life science research, particularly in genomics, proteomics, and cellular analysis to support molecular diagnostics and human identification.
Quanterix Corporation is developing a novel platform for single molecule analysis that will bring an unprecedented level of sensitivity, precision, and assay robustness to clinical diagnostics, drug development, and life science research.
A nanotechnology company devoted to developing, and commercializing the Personal Laboratory System™, a lab-on-a-chip analysis platform for droplet-based ('digital') microfluidics.
The company has developed its proprietary nano-Pore Optical lnterferometry (nPOI) platform for biomolecular interaction analysis.
The company develops biosensor technology that incorporates a proprietary nanostructured optical grating,
T2 Biosystems is creating a new generation of lab-quality diagnostic tools. Its technology is based on superparamagnetic nanoparticles. NanoDx particles have a superparamagnetic metal core surrounded by a polymer layer decorated by multiple analyte-specific binding agents. This nanoparticle platform can be used with a variety of binding agents such as antibodies, nucleic acids and small molecules.
The company sells nanowire sensing devices for molecular diagnostics - real-time, continuous flow and label free over 5 logs dynamic range to 10s of fm/mL sensitivity of proteins, nucleic acid and viruses. Virus LOD is single viruses.